awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42370827-225F891A-58E8-4678-A2A6-8023090D1584
Q42370827-225F891A-58E8-4678-A2A6-8023090D1584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42370827-225F891A-58E8-4678-A2A6-8023090D1584
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments
P2860
Q42370827-225F891A-58E8-4678-A2A6-8023090D1584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42370827-225F891A-58E8-4678-A2A6-8023090D1584
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be2bc4f8cec17910f6864dfc868b1b9e7dbc2e25
P2860
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.